Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays (Q38452406)

3 September 2017

Evaluation of HER-2/neu oncogene status in breast tumors on tissue microarrays (English)

1 reference

3 September 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733117

gene expression profiling

30 December 2023

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733117

30 December 2023

2

Manuel Salto-Tellez

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733117

30 December 2023

author name string

Daohai Zhang

1

1 reference

3 September 2017

Elaine Do

3

1 reference

3 September 2017

Thomas Choudary Putti

4

1 reference

3 September 2017

Evelyn S. C. Koay

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A12733117

30 December 2023

language of work or name

English

0 references

publication date

1 April 2003

1 reference

full work available at URL

3 September 2017

https://api.elsevier.com/content/article/PII:S0046817703000157?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1053/HUPA.2003.60

https://api.elsevier.com/content/article/PII:S0046817703000157?httpAccept=text/plain

30 December 2023

1 reference

https://api.crossref.org/works/10.1053/HUPA.2003.60

30 December 2023

1 reference

3 September 2017

34

1 reference

3 September 2017

4

1 reference

3 September 2017

362-368

1 reference

Localization of the human erbB-2 gene on normal and rearranged chromosomes 17 to bands q12-21.32.

3 September 2017

https://api.crossref.org/works/10.1053/HUPA.2003.60

1

1 reference

Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

2

1 reference

Detection and quantitation of HER-2/neu gene amplification in human breast cancer archival material using fluorescence in situ hybridization

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

4

1 reference

ERBB2 amplification in breast cancer analyzed by fluorescence in situ hybridization

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

5

1 reference

Detection of HER-2/neu (c-erb B-2) DNA amplification in primary breast carcinoma. Interobserver reproducibility and correlation with immunohistochemical HER-2 overexpression.

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

6

1 reference

Heterodimerization and functional interaction between EGF receptor family members: a new signaling paradigm with implications for breast cancer research

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

7

1 reference

Detection of numerical aberration in chromosome 17 and c-erbB2 gene amplification in epithelial ovarian cancer using recently established dual color FISH

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

8

1 reference

Status of c-erbB-2 in gastric adenocarcinoma: a comparative study of immunohistochemistry, fluorescence in situ hybridization and enzyme-linked immuno-sorbent assay

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

10

1 reference

Evaluation of HER-2/neu gene amplification and protein expression in non-small cell lung carcinomas

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

11

1 reference

Predictive role of HER-2/neu overexpression and clinical features at initial presentation in patients with extensive stage small cell lung carcinoma

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

12

1 reference

Multinational study of the efficacy and safety of humanized anti-HER2 monoclonal antibody in women who have HER2-overexpressing metastatic breast cancer that has progressed after chemotherapy for metastatic disease

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

13

1 reference

Association of c-erbB-2 protein over-expression with high rate of cell proliferation, increased risk of visceral metastasis and poor long-term survival in breast cancer.

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

14

1 reference

Quantitative evaluation of HER-2/neu status in breast cancer by fluorescence in situ hybridization and by immunohistochemistry with image analysis

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

15

1 reference

Aneusomy 17 in breast cancer: its role in HER-2/neu protein expression and implication for clinical assessment of HER-2/neu status

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

16

1 reference

Determination of Her-2/Neu status in breast carcinoma: comparative analysis of immunohistochemistry and fluorescent in situ hybridization

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

17

1 reference

Protein overexpression and gene amplification of c-erbB-2 in breast carcinomas: a comparative study of immunohistochemistry and fluorescence in situ hybridization of formalin-fixed, paraffin-embedded tissues

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

18

1 reference

HER-2/neu testing in breast carcinoma: a combined immunohistochemical and fluorescence in situ hybridization approach

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

19

1 reference

Discrepancies in clinical laboratory testing of eligibility for trastuzumab therapy: apparent immunohistochemical false-positives do not get the message

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

20

1 reference

HER-2/neu gene amplification characterized by fluorescence in situ hybridization: poor prognosis in node-negative breast carcinomas

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

21

1 reference

Comparison of HER-2/neu oncogene amplification detected by fluorescence in situ hybridization in lobular and ductal breast cancer

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

22

1 reference

Prognostic significance of p34cdc2 cyclin-dependent kinase and MIB1 overexpression, and HER-2/neu gene amplification detected by fluorescence in situ hybridization in breast cancer

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

23

1 reference

Contribution of fluorescence in situ hybridization to immunohistochemistry for the evaluation of HER-2 in breast cancer

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

24

1 reference

Tissue microarrays for high-throughput molecular profiling of tumor specimens

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

25

1 reference

Reliability of tissue microarrays in detecting protein expression and gene amplification in breast cancer

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

26

1 reference

Comparison of fluorescence in situ hybridization and immunohistochemistry for the evaluation of HER-2/neu in breast cancer

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

27

1 reference

Amplification of Her-2/neu gene in Her-2/neu-overexpressing and -nonexpressing breast carcinomas and their synchronous benign, premalignant, and metastatic lesions detected by FISH in archival material

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

28

1 reference

Assessment of methods for tissue-based detection of the HER-2/neu alteration in human breast cancer: a direct comparison of fluorescence in situ hybridization and immunohistochemistry

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

29

1 reference

Laboratory assessment of the status of Her-2/neu protein and oncogene in breast cancer specimens: comparison of immunohistochemistry assay with fluorescence in situ hybridisation assays

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

30

1 reference

HER-2/neu gene amplification status in prostate cancer by fluorescence in situ hybridization

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

32

1 reference

Overexpression of HER-2/neu and its relationship with other prognostic factors change during the progression of in situ to invasive breast cancer

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

33

1 reference

Strong correlation between results of fluorescent in situ hybridization and immunohistochemistry for the assessment of the ERBB2 (HER-2/neu) gene status in breast carcinoma

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

34

1 reference

HER-2/neu gene amplification compared with HER-2/neu protein overexpression and interobserver reproducibility in invasive breast carcinoma

30 December 2023

https://api.crossref.org/works/10.1053/HUPA.2003.60

35

1 reference

30 December 2023

Identifiers

DOI

10.1053/HUPA.2003.60

1 reference

3 September 2017

1 reference